This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Watkins, H. Articles by Seidman, C. E. Search for Related Content PubMed PubMed Citation Articles by Watkins, H. Articles by Seidman, C. E.

(Circulation. 1995;91:2302-2305.)
© 1995 American Heart Association, Inc.

Articles

A De Novo Mutation in -Tropomyosin That Causes Hypertrophic Cardiomyopathy

Hugh Watkins, MRCP; Ryuichiro Anan, MD; Domenico A. Coviello, MD, PhD; Paolo Spirito, MD; J.G. Seidman, PhD; Christine E. Seidman, MD

From the Cardiology Division, Brigham and Women's Hospital, and Harvard Medical School, Boston, Mass (H.W., R.A., C.E.S.); the Department of Cardiological Sciences, St George's Hospital Medical School, London, England (H.W.); the Institute of Biology and Genetics, University of Genoa (Italy) (D.A.C.); the Division of Cardiology, Ospedali Galliera, Genoa, Italy (P.S.); and Howard Hughes Medical Institute and Department of Genetics, Harvard Medical School, Boston, Mass (J.G.S.).

Correspondence to Hugh Watkins, Department of Genetics, Harvard Medical School, 200 Longwood Ave, Boston, MA 02115.

Background Two missense mutations in the gene for -tropomyosin have been described that segregate with hypertrophic cardiomyopathy in single families. To confirm that these mutations are the cause of the disease, we have investigated the origins of one of these mutations, Asp175Asn, in a third and unrelated family.

Methods and Results The presence or absence of an -tropomyosin mutation and the haplotypes of the flanking chromosomal regions were determined for members of a family with hypertrophic cardiomyopathy. Haplotypes were constructed by use of an intragenic polymorphism and 10 flanking polymorphisms spanning a region of 35 centimorgans. The Asp175Asn missense mutation was present in the proband and his two affected offspring but not in any of the proband's three siblings. Although both parents were deceased, the haplotypes of the four parental chromosomes could be reconstructed. One parental chromosome was transmitted to two offspring: one bearing the Asp175Asn mutation (the affected proband) and one clinically unaffected sibling who lacked the -tropomyosin mutation. Thus, the Asp175Asn mutation must have arisen de novo.

Conclusions De novo mutations in the -tropomyosin gene can result in hypertrophic cardiomyopathy that may appear to be sporadic but in subsequent generations gives rise to familial disease. Individuals with sporadic hypertrophic cardiomyopathy should be advised of the risk of transmission to offspring. In addition, these findings provide the strongest genetic evidence that mutations in the -tropomyosin gene are directly responsible for hypertrophic cardiomyopathy.

Key Words: cardiomyopathy • hypertrophy • genes

This article has been cited by other articles:

				P. Richard, E. Villard, P. Charron, and R. Isnard The Genetic Bases of Cardiomyopathies J. Am. Coll. Cardiol., October 27, 2006; 48(9_Suppl_A): A79 - A89. [Abstract] [Full Text] [PDF]

				D. Wernicke, C. Thiel, C. M. Duja-Isac, K. V. Essin, M. Spindler, D. J. R. Nunez, R. Plehm, N. Wessel, A. Hammes, R.-J. Edwards, et al. {alpha}-Tropomyosin mutations Asp175Asn and Glu180Gly affect cardiac function in transgenic rats in different ways Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2004; 287(3): R685 - R695. [Abstract] [Full Text] [PDF]

				E. Gilbert-Barness Metabolic Cardiomyopathy and Conduction System Defects in Children Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 15 - 34. [Abstract] [Full Text] [PDF]

				A.J. Marian and R. Roberts To Screen or Not Is Not the Question-- It Is When and How to Screen Circulation, May 6, 2003; 107(17): 2171 - 2174. [Full Text] [PDF]

				R. J. Jongbloed, C. L. Marcelis, P. A. Doevendans, J. M. Schmeitz-Mulkens, W. G. Van Dockum, J. P. Geraedts, and H. J. Smeets Variable clinical manifestation of a novel missense mutation in the alpha-tropomyosin (TPM1) gene in familial hypertrophic cardiomyopathy J. Am. Coll. Cardiol., March 19, 2003; 41(6): 981 - 986. [Abstract] [Full Text] [PDF]

				P Charron, D Heron, M Gargiulo, P Richard, O Dubourg, M Desnos, J-B Bouhour, J Feingold, L Carrier, B Hainque, et al. Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience J. Med. Genet., October 1, 2002; 39(10): 741 - 746. [Abstract] [Full Text] [PDF]

				O. M. Hernandez, P. R. Housmans, and J. D. Potter Plasticity in Skeletal, Cardiac, and Smooth Muscle: Invited Review: Pathophysiology of cardiac muscle contraction and relaxation as a result of alterations in thin filament regulation J Appl Physiol, March 1, 2001; 90(3): 1125 - 1136. [Abstract] [Full Text] [PDF]

				A. Karibe, L. S. Tobacman, J. Strand, C. Butters, N. Back, L. L. Bachinski, A. E. Arai, A. Ortiz, R. Roberts, E. Homsher, et al. Hypertrophic Cardiomyopathy Caused by a Novel {{alpha}}-Tropomyosin Mutation (V95A) Is Associated With Mild Cardiac Phenotype, Abnormal Calcium Binding to Troponin, Abnormal Myosin Cycling, and Poor Prognosis Circulation, January 2, 2001; 103(1): 65 - 71. [Abstract] [Full Text] [PDF]

				B. Mayosi, E. Blair, H. Watkins, D. Li, T. Tapscott, O. Gonzalez, M. A. Quinones, W. A. Zoghbi, R. Hill, L. L. Bachinski, et al. Dilated Cardiomyopathy and the Desmin Gene Response Circulation, September 26, 2000; 102 (13): e100 - e101. [Full Text] [PDF]

				L. G D'CRUZ, C. BABOONIAN, H. E PHILLIMORE, R. TAYLOR, P. M ELLIOTT, A. VARNAVA, F. DAVISON, W. J MCKENNA, and N. D CARTER Cytosine methylation confers instability on the cardiac troponin T gene in hypertrophic cardiomyopathy J. Med. Genet., September 1, 2000; 37(9): 18e - 18. [Full Text]

				M. C. Hart and J. A. Cooper Vertebrate Isoforms of Actin Capping Protein {beta} Have Distinct Functions in Vivo J. Cell Biol., December 13, 1999; 147(6): 1287 - 1298. [Abstract] [Full Text] [PDF]

				B. J. Maron, J. H. Moller, C. E. Seidman, G. M. Vincent, H. C. Dietz, A. J. Moss, J. A. Towbin, H. M. Sondheimer, R. E. Pyeritz, G. McGee, et al. Impact of Laboratory Molecular Diagnosis on Contemporary Diagnostic Criteria for Genetically Transmitted Cardiovascular Diseases: Hypertrophic Cardiomyopathy, Long-QT Syndrome, and Marfan Syndrome : A Statement for Healthcare Professionals From the Councils on Clinical Cardiology, Cardiovascular Disease in the Young, and Basic Science, American Heart Association Circulation, October 6, 1998; 98(14): 1460 - 1471. [Full Text] [PDF]

				R. Bottinelli, D. A. Coviello, C. S. Redwood, M. A. Pellegrino, B. J. Maron, P. Spirito, H. Watkins, and C. Reggiani A Mutant Tropomyosin That Causes Hypertrophic Cardiomyopathy Is Expressed In Vivo and Associated With an Increased Calcium Sensitivity Circ. Res., January 23, 1998; 82(1): 106 - 115. [Abstract] [Full Text] [PDF]

				P. Spirito, C. E. Seidman, W. J. McKenna, and B. J. Maron The Management of Hypertrophic Cardiomyopathy N. Engl. J. Med., March 13, 1997; 336(11): 775 - 785. [Full Text] [PDF]

				A.J. Marian and R. Roberts Recent Advances in the Molecular Genetics of Hypertrophic Cardiomyopathy Circulation, September 1, 1995; 92(5): 1336 - 1347. [Full Text]